pomalidomide cost?

Best Answer

Pomalidomide is tumor necrosis factor-α inhibitor and a new immunomodulator with an IC50 of 1 μM. Find all the information about Pomalidomide for cell signaling ... - read more

Second Best Answer

POMALYST ® (pomalidomide) is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma who have received at least two ... - read more

Please vote if the answer you were given helped you or not, thats the best way to improve our algorithm. You can also submit an answer or search documents about how do you transfer songs from our ipod to my son s new mp3 player.

pomalidomide cost? community answers

pomalidomide cost Similar Questions

pomalidomide cost Resources

Compare prices and print coupons for Pomalidomide and other Multiple Myeloma drugs at CVS, Walgreens, and other pharmacies. Prices start at $13727.50 ... read more
Feb 07, 2013 · The United States Food and Drug Administration (FDA) has approved pomalidomide, which will be marketed under the brand name Pomalyst, for the treatment of ... ... read more
POMALYST ® (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have previously ... ... read more
Easy to read patient leaflet for pomalidomide. Includes indications, proper use, special instructions, precautions, and possible side effects. ... read more
Pomalidomide: learn about side effects, dosage, special precautions, and more on MedlinePlus ... read more
Pomalyst Prices, Coupons and Patient Assistance Programs. Pomalyst (pomalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly used for ... ... read more
Oct 08, 2015 · Pomalidomide is approved with a Boxed Warning alerting patients and healthcare professionals that the drug can cause embryo-fetal toxicity and venous ... ... read more
Pomalidomide enhances SEE and Raji cells induced AP-1 transcriptional activity in Jurkat cells in a dose-dependent manner, with a maximal enhancement of 4-fold at 1 ... ... read more
Feb 12, 2013 · On Friday, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) for the treatment of multiple myeloma patients who have received at ... ... read more
Pomalidomide is the most potent of the 3, he told Medscape Medical News in an interview here at the American Society of Hematology (ASH) 45th Annual Meeting. ... read more
Medscape - Multiple myeloma dosing for Pomalyst (pomalidomide), frequency-based adverse effects, comprehensive interactions, ... and cost information. ... ... read more
Pomalidomide (Pomalyst) immunomodulatory agent side effects, how it's given, how it works, precautions and self care tips for treatment of multiple myeloma ... read more
Pomalyst (pomalidomide) is an immunomodulatory drug used to treat patients with multiple myeloma, a type of cancer that affects white blood cells. ... read more
Moved Permanently. The document has moved here. ... read more
HIGHLIGHTS OF PRESCRIBING INFORMATION ... (pomalidomide) capsules, for oral use Initial US Approval: 2013 . WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM . ... read more
Learn about Pomalyst (Pomalidomide Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. ... read more
Pomalidomide (INN, codenamed CC-4047, also known as 3-amino-thalidomide, trade name Pomalyst in the U.S. and Imnovid in EU and Russia) is a derivative of thalidomide ... ... read more
Medicare coverage and pricing details for Pomalidomide. Learn more about Medicare prescription drug plans and savings with GoodRx. ... read more
Pomalidomide (pronounced pom-a-lid-oh-mide) is a type of biological therapy drug. It is also known by its brand name, Imnovid (pronounced imm-know-vid). ... read more
Pomalyst is a potent oral immunomodulatory drug. Pomalyst is also known as Pomalidomide. Pomalyst is taken orally to slow or kill multiple myeloma cancer cells. ... read more
Pomalidomide is indicated for the treatment of multiple myeloma. Pomalidomide is a thalidomide analogue, which exerts an immunomodulatory antineoplastic effect by the ... ... read more
Lenalidomide (trade name Revlimid) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which ... ... read more
The oral therapy pomalidomide (Pomalyst, Celgene) was approved by the US Food and Drug Administration today for use in the treatment of multiple myeloma. ... read more
Welcome to the POMALYST REMS ® program. POMALYST ® (pomalidomide), in combination with dexamethasone, is indicated for patients with multiple myeloma who have ... ... read more
Manus Aktteva Biopharma LLP, a global supplier of Pomalidomide, 19171-19-8 offers for your requirements of RND / Development quantities or commercials, based on ... ... read more
POMALYST (Pomalidomide) Capsules IMNOVID (Pomalidomide) Capsules. Description of Imnovid (Pomalidomide) Imnovid (Pomalyst) is a derivative of thalidomide marketed by ... ... read more
Pomalidomide Celgene® (pomalidomide) Introduction The Horizons Infosheet series provides information relating to novel drugs that are currently being investigated ... ... read more
This guidance has been updated and replaced by pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib ... read more